PT3558458T - Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca - Google Patents

Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca

Info

Publication number
PT3558458T
PT3558458T PT178847570T PT17884757T PT3558458T PT 3558458 T PT3558458 T PT 3558458T PT 178847570 T PT178847570 T PT 178847570T PT 17884757 T PT17884757 T PT 17884757T PT 3558458 T PT3558458 T PT 3558458T
Authority
PT
Portugal
Prior art keywords
hydroxybutyrates
glyceryl
symptom management
migraine symptom
migraine
Prior art date
Application number
PT178847570T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Neuroenergy Ventures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroenergy Ventures Inc filed Critical Neuroenergy Ventures Inc
Publication of PT3558458T publication Critical patent/PT3558458T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT178847570T 2016-12-23 2017-11-30 Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca PT3558458T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/389,828 US20180177753A1 (en) 2016-12-23 2016-12-23 Glyceryl 3-hydroxybutyrates for migraine symptom management

Publications (1)

Publication Number Publication Date
PT3558458T true PT3558458T (pt) 2023-11-27

Family

ID=62624821

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178847570T PT3558458T (pt) 2016-12-23 2017-11-30 Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca

Country Status (13)

Country Link
US (2) US20180177753A1 (enExample)
EP (1) EP3558458B1 (enExample)
JP (1) JP7108320B2 (enExample)
KR (1) KR102390608B1 (enExample)
CN (1) CN110167637B (enExample)
BR (1) BR112019012431A2 (enExample)
CA (1) CA3046350C (enExample)
ES (1) ES2962879T3 (enExample)
IL (1) IL267540B (enExample)
MX (1) MX389468B (enExample)
MY (1) MY190308A (enExample)
PT (1) PT3558458T (enExample)
WO (1) WO2018118369A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
EP4245368A3 (en) 2016-12-21 2024-01-03 Universitäts-kinderspital Beider Basel Migraine prevention and treatment
US10376528B2 (en) 2017-03-10 2019-08-13 Tecton Group, Llc Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
GB201715654D0 (en) 2017-09-27 2017-11-08 Tdeltas Ltd Method of treatment
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US12091383B2 (en) * 2019-01-17 2024-09-17 Ketolipix Therapeutics Gmbh Method for producing lipids comprising structural units based on glycerides of hydroxycarboxylc acids
JP7235873B2 (ja) * 2019-01-17 2023-03-08 アイオーアイ オレオ ゲーエムベーハー ヒドロキシカルボン酸のグリセリドの製造方法
JP7287709B2 (ja) * 2019-03-14 2023-06-06 ニューロエナジー ベンチャーズ、インコーポレイテッド ケトン体化合物用風味マスキング製剤
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
IL288343B2 (en) * 2019-05-30 2024-04-01 Neuroenergy Ventures Inc Glyceryl tris (beta-hydroxybutyrate) and neuronal transient ischemic attacks
US20250197566A1 (en) * 2019-06-12 2025-06-19 Ioi Oleo Gmbh Process for preparing polyol-based esters of acyl-capped hydroxy carboxylic acids
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
IT201900018491A1 (it) * 2019-10-10 2021-04-10 Dr Schaer S P A Procedimento di purificazione del tris-(3-idrossibutirrato)-gliceril estere
IT201900018488A1 (it) * 2019-10-10 2021-04-10 Dr Schaer S P A Procedimento di preparazione del tris-(3-idrossibutirrato)-gliceril estere
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
IL312317B2 (en) * 2021-11-12 2025-04-01 Arxada Ag Polyol-derived compounds
US20250002446A1 (en) * 2021-11-26 2025-01-02 Arxada Ag Acetoacetate Based Ketals
US12023382B2 (en) 2022-01-18 2024-07-02 Today Inc. Molecules, formulations, and methods for nutritional support of athletes, patients, and others
US20240299548A1 (en) * 2022-01-18 2024-09-12 Today, Inc. Molecules, formulations, and methods for nutritional support of athletes, patients, and others
EP4605371A1 (en) 2022-10-18 2025-08-27 Arxada AG Polyol-derived compounds
WO2025074001A2 (en) 2023-10-05 2025-04-10 Arxada Ag Enzymatic reduction of acetoacetate
WO2025196156A1 (en) 2024-03-20 2025-09-25 Arxada Ag Continuous hydrogenation process of acetoacetate esters
WO2025224319A1 (en) 2024-04-25 2025-10-30 Arxada Ag Reduction of acetoacetate esters in the presence of amines

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0420856D0 (en) 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
KR20090003148A (ko) 2006-04-03 2009-01-09 액세라인크 나이와 관련된 기억 손상의 치료를 위한 케톤 생성조성물의 용도
WO2008005818A1 (en) 2006-06-30 2008-01-10 Stepan Co Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
EA201190115A1 (ru) * 2009-01-24 2012-02-28 ФИТОФАРМ ПиЭлСи Лечение расстройств, опосредованных нейротрофическим фактором
CA2873057C (en) 2011-05-09 2020-02-25 University Of South Florida The use of ketone esters for prevention of cns oxygen toxicity
US20140072654A1 (en) 2011-12-23 2014-03-13 Savind, Inc. Cancer with metabolic therapy and hyperbaric oxygen
FR2997302B1 (fr) * 2012-10-29 2015-02-06 Assist Publ Hopitaux De Paris Prevention et traitement des deficits en pyruvate deshydrogenase
DK2914251T3 (da) 2012-11-05 2019-11-04 Us Health Ketonlegemer til beskyttelse af væv mod beskadigelse som følge af ioniseringsstråling
EP2925308B1 (en) 2012-11-28 2019-12-25 University Of South Florida Targeting cancer with metabolic therapy and hyperbaric oxygen
PE20151949A1 (es) 2013-03-19 2016-01-05 Univ South Florida Composiciones y metodos para producir cetosis elevada y sostenida
GB201314127D0 (en) 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown
CA2973342A1 (en) 2014-01-13 2015-10-15 University Of South Florida Methods of sustaining dietary ketosis and its effects on lipid profile
US20160078782A1 (en) * 2014-09-17 2016-03-17 The Trustees Of Boston College Glucose Ketone Index for MetabolicTherapy
US9364456B1 (en) 2015-06-30 2016-06-14 University Of South Florida Ketone esters for treatment of angelman syndrome
WO2017011294A1 (en) 2015-07-10 2017-01-19 Cognate Nutritionals, Inc. Prophylaxis and mitigation of migraine headaches using medium chain triglycerides, ketone esters, and other ketogenic sources
US10292952B2 (en) 2016-03-11 2019-05-21 Axcess Global Sciences, Llc Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
US10376482B2 (en) 2016-04-03 2019-08-13 Franco Cavaleri Butyrate and beta-hydroxybutyrate compositions
CA3021784A1 (en) 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
WO2018009208A1 (en) 2016-07-08 2018-01-11 Cognate Nutritionals, Inc. Nutritional mitiggation of the cns effects of traumatic brain injury
CA3036688A1 (en) 2016-09-12 2018-03-15 University Of South Florida Neuroregeneration improved by ketone
EP4245368A3 (en) 2016-12-21 2024-01-03 Universitäts-kinderspital Beider Basel Migraine prevention and treatment

Also Published As

Publication number Publication date
EP3558458A4 (en) 2020-08-12
MX2019006844A (es) 2019-08-16
US10792269B2 (en) 2020-10-06
US20180177753A1 (en) 2018-06-28
MY190308A (en) 2022-04-13
JP2020502250A (ja) 2020-01-23
JP7108320B2 (ja) 2022-07-28
CA3046350C (en) 2022-08-16
BR112019012431A2 (pt) 2020-04-14
EP3558458A1 (en) 2019-10-30
CN110167637B (zh) 2023-03-14
IL267540B (en) 2022-07-01
WO2018118369A1 (en) 2018-06-28
CA3046350A1 (en) 2018-06-28
IL267540A (en) 2019-08-29
KR102390608B1 (ko) 2022-04-25
MX389468B (es) 2025-03-20
EP3558458B1 (en) 2023-10-18
KR20190099465A (ko) 2019-08-27
CN110167637A (zh) 2019-08-23
ES2962879T3 (es) 2024-03-21
US20190117612A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
IL267540A (en) Glyceryl 3-hydroxybutyrates for managing migraine symptoms
ZA201605946B (en) Treatments for resistant acne
GB2512545B (en) Update management
GB201401715D0 (en) Exfoliation
GB201415067D0 (en) Authentication management
GB2536880B (en) Memory management
GB2536200B (en) Memory management
GB2537960B (en) Memory management
GB201620954D0 (en) Memory management
GB201820012D0 (en) Stock monitoring
GB2536199B (en) Memory management
GB201400853D0 (en) Emergency access bolt
GB2529906B (en) Stock Monitoring
AU358772S (en) Stirrup
SG11201702458RA (en) Operation management
ZA201509306B (en) Inventory management
SG10201501070UA (en) Elevator-group management system
GB201604125D0 (en) Co-crystal
GB201502124D0 (en) Litter box
GB201900707D0 (en) Stock monitoring
GB201900708D0 (en) Stock monitoring
GB201403437D0 (en) Easy click box
GB2555047B (en) Distribution box
GB2525040B (en) Ear tie
GB201413144D0 (en) Enclosure